Study of proliferation and apoptosis in neuroblastoma.: Their relation with other prognostic factors

被引:13
|
作者
Mejía, MD [1 ]
Navarro, S
Pellín, A
Ruíz, A
Castel, V
Llombart-Bosch, A
机构
[1] Univ Nacl Autonoma Mexico, Lab LB 302, Dept Neurosci, Inst Fisiol Celular,CU, Mexico City 04510, DF, Mexico
[2] Univ Valencia, Fac Med, Dept Patol, Valencia, Spain
[3] Hosp La Fe, Unidad Oncol Pediat, E-46009 Valencia, Spain
关键词
neuroblastoma; proliferation; apoptosis; prognostic factors;
D O I
10.1016/S0188-4409(02)00384-3
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Background. Our objective was to study the proliferation and apoptotic process in 111 cases of neuroblastoma (NB) and to seek their relationship with other prognostic factors and survival. Methods. Immunohistochemistry following ABC peroxidase was carried out for PCNA, Ki-67, bcl-2, and p53 proteins. Apoptosis analysis was performed with in situ detection of chromosomal breakdown. Molecular detection of DNA ladders by electrophoresis and amplification of MYCN was studied with PCR and Southern blot. Statistical study was performed with Pearson chi(2) and Kruskal-Wallis tests and Cox regression. Results. Our results indicate that proliferative factors PCNA and Ki-67 were correlated to each other as well as to advanced stage and MYCN amplification. Regarding apoptosis, we found expression of bcl-2 protein in cases of NB without differentiation and advanced stages. p53 protein showed an inverse relation with bcl-2 and cell death measured by assay protein. In situ determination of apoptosis was found mainly in differentiated and stage 4s cases. Multivariate analysis revealed protein as the most independent risk factor of our study. Conclusions. The study of cellular proliferation and apoptosis contributes with information of prognostic value that could be applied to the design of different protocols for treatment of neuroblastoma. (C) 2002 IMSS. Published by Elsevier Science Inc.
引用
收藏
页码:466 / 472
页数:7
相关论文
共 50 条
  • [41] OUTCOME AND PROGNOSTIC FACTORS IN OLFACTORY NEUROBLASTOMA: A RARE CANCER NETWORK STUDY
    Ozsahin, Mahmut
    Gruber, Guenther
    Olszyk, Olimpia
    Karakoyun-Celik, Omur
    Pehlivan, Berrin
    Azria, David
    Roelandts, Martine
    Kaanders, Johannes H. A. M.
    Cengiz, Mustafa
    Krengli, Marco
    Matzinger, Oscar
    Zouhair, Abderrahim
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 78 (04): : 992 - 997
  • [42] Treatment of localised resectable neuroblastoma. Results of the LNESG1 study by the SIOP Europe Neuroblastoma Group
    De Bernardi, B.
    Mosseri, V.
    Rubie, H.
    Castel, V.
    Foot, A.
    Ladenstein, R.
    Laureys, G.
    Beck-Popovic, M.
    de Lacerda, A. F.
    Pearson, A. D. J.
    De Kraker, J.
    Ambros, P. F.
    de Rycke, Y.
    Conte, M.
    Bruzzi, P.
    Michon, J.
    BRITISH JOURNAL OF CANCER, 2008, 99 (07) : 1027 - 1033
  • [43] APOPTOSIS BY ANTITUMOR AGENTS AND OTHER FACTORS IN RELATION TO CELL-CYCLE CHECKPOINTS
    KONDO, S
    JOURNAL OF RADIATION RESEARCH, 1995, 36 (01) : 56 - 62
  • [44] Proliferation and apoptosis genes as prognostic and predictive factors in breast cancer: towards personalized medicine
    Maldonado-Martinez, Hector
    Angel Pluma-Jimenez, Miguel
    Grajales-Alvarez, Rocio
    Guadarrama-Orozco, Jorge
    Valero-Castillo, Vicente
    Silva, Alejandro
    Javier Ochoa-Carrillo, Francisco
    Baeza-Ramirez, Isabel
    Astudillo-de la Vega, Horacio
    GACETA MEXICANA DE ONCOLOGIA, 2011, 10 (04): : 210 - 221
  • [45] Apoptosis of myocytes and proliferation markers as prognostic factors in end-stage dilated cardiomyopathy
    Zorc, M
    Vraspir-Porenta, O
    Zorc-Pleskovic, R
    Radovanovic, N
    Petrovic, D
    CARDIOVASCULAR PATHOLOGY, 2003, 12 (01) : 36 - 39
  • [46] Expression of inhibitor-of-apoptosis protein (IAP) livin by neuroblastoma cells: Correlation with prognostic factors and outcome
    Kim, DK
    Alvarado, CS
    Abramowsky, CR
    Gu, LB
    Zhou, MX
    Soe, MM
    Sullivan, K
    George, B
    Schemankewitz, E
    Findley, HW
    PEDIATRIC AND DEVELOPMENTAL PATHOLOGY, 2005, 8 (06) : 621 - 629
  • [47] MULTIVARIATE EVALUATION OF PROGNOSTIC FACTORS IN LOCALIZED NEUROBLASTOMA
    BERTHOLD, F
    KASSENBOHMER, R
    ZIESCHANG, J
    AMERICAN JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 1994, 16 (02): : 107 - 115
  • [48] Analyses of novel prognostic factors in neuroblastoma patients
    Ootsuka, Susumu
    Asami, Satoru
    Sasaki, Takae
    Yoshida, Yoshikazu
    Nemoto, Normichi
    Shichino, Hiroyuki
    Chin, Motoaki
    Mugishima, Hideo
    Suzuki, Takashi
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2007, 30 (12) : 2294 - 2299
  • [49] CHROMOGRANIN A IN NEUROBLASTOMA: CORRELATION TO STAGE AND PROGNOSTIC FACTORS
    Georgantzi, K.
    Skoldenberg, E.
    Stridsberg, M.
    Jakobson, A.
    Christofferson, R.
    PEDIATRIC BLOOD & CANCER, 2013, 60 : 228 - 228
  • [50] Prognostic Factors of Neuroblastoma: A Retrspective Study about 56 Cases in the Center of Tunisia
    Chabchoub, I.
    Hiba, S.
    Fallah, S.
    Ammar, N.
    Bouzid, N.
    Mosbahi, S.
    Hmida, D.
    Ezzairi, F.
    Belaid, I.
    Hochlef, M.
    Ben Fatma, L.
    Belghith, M.
    Zakhama, A.
    Ben Ahmed, S.
    PEDIATRIC BLOOD & CANCER, 2021, 68 : S467 - S467